SRT Sartorius AG

Sartorius AG (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, will be admitted to the TecDAX technology index. This was announced yesterday on Tuesday evening by the German stock exchange organization, Deutsche B�rse Group. Thus, the Sartorius preference share will be traded as of June 18, 2012, in the German index of technology stocks.

The TecDAX is the leading index of the 30 largest and most liquid German technology stocks, and ranks just under the DAX, the blue-chip German Stock Index. Criteria for admission to the TecDAX are free-float market capitalization at the time the shares are reviewed and stock exchange turnover of the past 12 months.

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius, welcomed the decision of Deutsche B�rse. “By moving up to the TecDAX, our company and our shares will gain additional attention and become even more attractive. I am confident that in the future as well, we will continue to drive our positive business performance that has contributed to our inclusion in this index.”

This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

A Profile of Sartorius

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of Bioprocess Solutions, Lab Products & Services and Industrial Weighing. In 2011, the technology group earned sales revenue of 733.1 million euros. Founded in 1870, the Goettingen-based company currently employs more than 5,000 persons. The major areas of activity of its Bioprocess Solutions segment cover filtration, fluid management, fermentation, cell cultivation and purification, and focus on production processes in the biopharmaceutical industry. The Lab Products & Services segment primarily manufactures laboratory instruments and consumables. Industrial Weighing concentrates on weighing, monitoring and control applications in the manufacturing processes of the food, chemical and pharma sectors. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

Sartorius (TG:SRT)
Historical Stock Chart
From Nov 2024 to Dec 2024

Sartorius (TG:SRT)
Historical Stock Chart
From Dec 2023 to Dec 2024